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Let food be thy medicine, thy medicine shall be thy food. 
 
–Hippocrates (460 BC –370 BC) 
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SUMMARY 
 
The increase of obesity that we have experienced during the last decades and its association 
with insulin resistance, type 2 diabetes and other metabolic diseases has resulted in an 
enormous interest for understanding the mechanisms underlying these disorders. Tissue 
inflammation triggered by food with a high glycemic index has been suggested to be an 
important mediator in the development of insulin resistance. Despite great research efforts 
lately, more research is needed in order to understand how nutrients interact with the genetic 
factors that control and triggers the inflammatory responses.  
The composition of macronutrients in a diet influences the levels of insulin secretion in the 
body. Besides controlling the blood glucose concentration, insulin also regulates a range of 
inflammatory processes. Inflammation is largely dependent on some small cell-signaling 
molecules called cytokines, as these activate a wide range of inflammatory-related genes.  
The objective of this study is to explore the regulatory effects of insulin and cytokines on the 
transcription of the following selected genes related to inflammation; D5D, D6D, SCD and 
FOXO3A. In addition, expression of TRAIL, BTG1 and TWIST1 is studied as they all are 
target genes for FOXO3A, and related to inflammatory processes and/or glucose metabolism. 
Quantitative-PCR was used to study mRNA expression of relevant genes in THP-1 cells 
treated with insulin and cytokines. 
As the investigation was performed on THP-1 monocytes, it was necessary to optimize the in 
vitro conditions in order to obtain a maximal response from the insulin and cytokine 
treatments. The concentration of insulin was an important factor in this study, because the 
regulation of FOXO3A and desaturases (D5D, D6D and SCD) mRNA expression seemed to 
be dose-dependent. The treatment period was also critical, as a set of time-course experiments 
revealed that FOXO3A and the desaturases were regulated by insulin and cytokines at 
different time-points.  
In this study, THP-1 cells treated with insulin and/or cytokines revealed significant 
regulations of the relevant genes. Gene expression of D5D, D6D and SCD was significantly 
up-regulated in response to insulin. Furthermore, mRNA expression of the transcription factor 
FOXO3A was significantly down-regulated by insulin, IL-1β and TNF-α. However, neither 
FOXO3A nor the desaturases were cooperatively regulated by these stimulating factors. 
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TRAIL, TWIST and BTG1 on the other hand, were significantly up-regulated in a synergistic 
manner when cells were treated with a combination of insulin, IL-1β and TNF-α.  
The observed regulation of gene expressions in THP-1 monocytes treated with insulin and 
cytokines suggests that insulin may affect the regulation of inflammatory related genes in 
circulating human monocytes. As insulin is secreted in the bloodstream followed by elevated 
levels of glucose after a meal, these results may reflect possible diet-induced changes in gene 
expression.  
  Sammendrag 
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SAMMENDRAG 
 
Økende tilfeller av fedme og fedme-relaterte lidelser som insulinresistans, type-2 diabetes og 
andre metabolske sykdommer har ført til en tiltagende interesse for å forstå de 
molekylærbiologiske mekanismene bak disse tilstandene. Kronisk betennelse trigget av mat 
med en høy glykemisk indeks antas nå for å være en viktig faktor i utviklingen av 
insulinresistens. Til tross for en allerede stor forskingsinnsats på dette feltet, kreves det 
ytterligere forskning for å forstå hvordan de ulike næringsstoffene og sammensetningen av 
dem påvirker de genetiske faktorene som regulerer inflammatoriske prosesser i kroppen.  
Kostholdsammensetningen påvirker insulinkonsentrasjonen i kroppen, ettersom insulin 
utskilles i blodet som følge av økt glukose nivå. I tillegg til å kontrollere blodsukkernivået i 
kroppen, er insulin en viktig regulator for en rekke inflammatoriske prosesser. Disse 
prosessene er i stor grad avhengig av signalmolekyler kalt cytokiner. Cytokiner aktiverer en 
rekke gen som spiller en viktig rolle i inflammatoriske prosesser.  
I dette studiet ble det undersøkt om insulin og cytokiner kunne påvirke transkripsjonen til 
følgende betennelses-relaterte gen: D5D, D6D, SCD og FOXO3A. I tillegg ble transkripsjon 
av TRAIL, BTG1 og TWIST1 studert ettersom de alle er målgener for FOXO3A, og i seg 
selv er relatert til inflammatoriske prosesser og/eller glukosemetabolismen. cDNA fra THP-1 
celler stimulert med insulin, IL-1β og TNF-α ble brukt som templat for kvantitativ PCR for å 
kvantifisere uttrykk av relevante gen i forhold til de ulike stimuleringene. 
Ettersom studiet ble utført i THP-1 monocytter, var det nødvendig å optimalisere 
stimuleringstid og konsentrasjon av stimuleringsfaktorene for å påvise eventuelle reguleringer 
av transkripsjon som følge av insulin og cytokiner. Insulinkonsentrasjonen viste seg å være en 
viktig faktor, ettersom regulering av desaturasene (D5D, D6D og SCD) og FOXO3A viste seg 
å være konsentrasjonsavhengig. Antall timer stimulering var også essensielt, da FOXO3A og 
desaturasene ble regulert av insulin og cytokiner ved spesifikke tidspunkt.  
Genuttrykk av D5D, D6D og SCD viste seg å være betydelig oppregulert i THP-1 celler 
stimulert med insulin. Transkripsjon av FOXO3A ble derimot betydelig nedregulert som følge 
av insulin stimulering. Denne nedreguleringen ble også observert i celler stimulert med IL-1β 
og TNF-α. En synergistisk effekt av insulin og cytokiner ble observert i reguleringen av 
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TRAIL, TWIST og BTG1 transkripsjon. Det ble i midlertidig ikke observert en kombinert 
effekt for transkripsjonsregulering av FOXO3A eller desaturasene. 
Ettersom genuttrykk ble regulert av insulin og cytokiner i THP-1 celler, er det mulig at disse 
observasjonene også forekommer i humane monocytter. Ettersom økt glukosekonsentrasjon 
trigger insulinutskillelse som følge av et måltid, kan disse resultatene reflektere mulige 
endringer i genuttrykk som følge av kostholdssammensetning. 
1. Abbrevations 
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1. ABBREVATIONS  
 
18s rRNA 18S ribosomal RNA 
AA Arachidonic acid 
ALA α-Linoleic acid 
B2M Beta-2-microglubin 
BLAST Nucleotide basic local alignment search tool 
CCL2 Chemokine (C-C motif) ligand 2 
cDNA Complementary DNA 
Cq Quantitative cycle 
D5D Delta-5-desaturase 
D6D Delta-6-desaturase 
DDB1 DNA-damage binding protein 1 
DGLA Dihomo-γ-linoleic acid 
DHA Docosaexaenoic acid 
DMSO Dimethylsulfoxide 
FA Fatty acids 
FBS Fetal bovine serum 
FCS Fetal calf serum 
FFA Free fatty acids 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GLA γ-Linoleic acid 
HPRT1 Hypoxanthine phosphoribosyl-transferase 1 
IGF-1 Insulin-like growth factor 1 
IL-1β Interleukin-1 beta 
IL-6 Interleukin-6 
IR Insulin receptor 
IRS Insulin receptor substrate 
LA Linoleic acid 
mRNA Messenger RNA 
MUFA Monounsaturated fatty acid 
NF-κB Nuclear factor κB 
OA Oleic acid 
PI3K Phosphatidylinositol-3 kinase 
PIP2 Phosphatidylinositol-4.5-biphosphate 
PIP3 Phosphatidylinositol-3.4.5-triphosphate 
1. Abbrevations 
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PUFA Polyunsaturated fatty acid 
qPCR Quantitative real-time polymerase chain reaction  
SCD Stearoyl-CoA desaturase 
SRE Sterol regulatory element 
SREBP-1c Sterol regulatory element binding factor 1c 
STA Stearidonic acid 
TG Triglycerides 
Tm Annealing temperature 
TNF-α Tumor necrosis factor alpha 
TRAIL Tumor necrosis factor-related apoptosis-inducing ligand 
TWIST1 Twist-related protein 1 
YBX1 Y box binding protein 1 
ω3 Omega 3 
ω6 Omega 6 
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2.  INRODUCTION 
 
2.1 Diet related disease risk 
 
Over the last 50 years, the occurrence of human obesity has escalated epidemically 
worldwide. By 2005, 1.6 billion adults were considered as overweight, and more than 400 
million were affected by obesity. As a consequence of this trend, the prevalence of obesity-
associated maladies such as type 2 diabetes (T2D), cardiovascular diseases (CVD) and certain 
forms of cancer have shown a tremendous increase [1]. 
As an action to the increasing number of obesity cases, the main focus has been to reduce the 
dietary intake of fat. Both the public and the food industry have followed recommendations 
given by health organizations worldwide. Although the recommended composition of the 
three macronutrients in food varies from country to country, the message has been the same; 
to decrease the dietary intake of fat, while increasing the dietary carbohydrate intake. 
According to The US department of Health and Human Services and the US Department of 
Agriculture dietary fat intake decreased from 40 E% to 33 E% from the 1960s to 1995 ,while 
the carbohydrate intake has increased from 45 E % to 52 E% in the same period. [2, 3] 
Even though the American and European population has adapted to the above mentioned 
recommendations, cardiovascular diseases are still considered as a number one cause of death, 
and cases of obesity and type 2 diabetes continue to rise. This trend has engaged researchers 
to examine the effect of the increased proportion of dietary carbohydrates relative to fat and 
proteins, and its possible harmful effects on human health.  
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2.2 Function and metabolism of dietary fats  
 
2.2.1 Dietary Fats 
 
There are a variety of types of fat, due to their different chemical structure and physical 
properties. A major part of dietary fats consists of triglycerides (TG), but fat also include 
cholesterol, phospholipids and free fatty acids (FFA). TGs are made up by triesters of glycerol 
and any kind of fatty acids, and constitute the majority of energy stored in the body [4].  
Besides being a source of energy, dietary fatty acids have a variety of functions required for 
normal growth and development. These biocompounds play a major role in a variety of 
metabolic pathways, and are also incorporated into the lipid bilayer of cell membranes.  Fatty 
acids are divided into two main groups; saturated- and unsaturated acids.  Unsaturated acid is 
further categorized as monounsaturated acids (MUFAs) and polyunsaturated fatty acids 
(PUFAs). In human beings, not all fatty acids can be synthesized de novo, due to lack of 
certain enzymes. Omega 3 (ω3) and omega 6 (ω6) PUFAs are essential for survival, but 
require a dietary intake of their precursor; Linoleic Acid (LA) and α-Linoleic Acid (ALA). 
Thus, these are considered as essential fatty acids [5] 
 
2.2.2 Desaturases in the metabolism of unsaturated fatty acids 
 
The biosynthesis of PUFAs is catalyzed by a set of enzymes known as fatty acid desaturases. 
There is a variety of desaturases, and they are all specific for the double bonds of the PUFA. 
Delta-5-desaturase (D5D) and Delta-6-desaturase (D6D) are responsible for the desaturation 
of LA and ALA in the biosynthesis of various ω6 and ω3 PUFAs [6]. 
In the first step of the ω6 PUFA pathway, LA is desaturated into γ-Linoleic acid (GLA, 18:3). 
ALA is desaturated by the same enzyme, but is converted to stearidonic acid (STA, 18:4) [7] 
(figure 1). The reaction is followed by an elongation step catalyzed by elongase which 
converts GLA to dihomo-γ-linoleic acid (DGLA, 20:3) and STA to eicosatetraenoic acid 
(20:4). D5D is responsible for the second desaturation in these two pathways. By introducing 
a double bond at carbon number 5, DGLA and eicosatetraenoic acid are desaturated to 
arachidonic acid (AA, 20:4) and eicosapentaenoic acid (EPA, 20:5). As a final step in the ω3-
  2. Introduction 
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pathway, docosaexaenoic acid (DHA, 22:6) may be synthesized from EPA through elongation 
and desaturation [6, 7]. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Metabolism of ω9, ω6 and ω3 PUFA in mammals. Modified figure [8].  
D5D and D6D do also act in the metabolism of MUFAs. In the biosynthesis of MUFAs, 
stearic acid (18:0) is desaturated to form oleic acid (OA (18:1) by stearoyl-CoA desaturase 
(SCD). SCD introduces a double bond at carbon number 9, and is therefore also called delta-
9-desaturase. D6D and D5D catalyze the further metabolism of OA [9].  
 
2.2.3 The role of unsaturated fatty acids in inflammation  
 
Inflammation caused by infection, irritation or other injury is a complex response and is 
characterized by redness, swelling, heat and pain. The classical, acute inflammation is a 
strictly regulated process, that will continue until the tissue damage is repaired or the 
pathogen is defeated [10]. PUFAs are important in inflammation as some of theme serve as 
ω9 FA      ω6 FA             ω3 FA 
Stearic acid (18:0)   
 
  Oleic acid (18:1)       Linoleic acid (18:2)    α-Linoleic acid (18:2) 
 
         (18:2)     γ-Linoleic acid (18:3)   Stearidonic acid (18:4) 
 
         (20:2)          Dihomo-γ-linoleic acid (20:3)          Eicosatetraenoic acid (20:4) 
 
         (20:3)   Arachidonic acid (20:4)          Eicosapentaenoic acid (20:5) 
 
                 
       Docosahexaenoic acid (22:6) 
 
D6D 
SCD 
D5D D5D 
D6D 
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precursors for metabolites in the initiation, progression or resolution of the process. 
Metabolites derived from the ω6 FA AA, such as the 2-series of prostaglandins, 
thromboxanes and the 4-series of leukotrienes act as pro-inflammatory compounds and 
activate responses like cytokine production [11]. However, some signal molecules made from 
AA may also act as key mediators of the resolution of the inflammatory process, like 
resolvins and lipoxins. This is also true for resolvins and protectins derived from ω3 FAs 
DGLA and GLA which has a number of anti-inflammatory properties [12].  
In modern diet, there are few sources of ω3 FAs, while ω6 FAs can be found in a range of 
different food items. Thus, most people obtain a high ω6 to ω3 ratio through their meals.  As 
metabolites derived from PUFAs have opposite roles regarding inflammation, there should be 
a balance between these. As D5D promote the formation of pro-inflammatory compounds as 
well as anti-inflammatory (see section 2.2.2), it is reasonable to believe that regulation of 
D5D should have antagonistic properties in the inflammatory process. But due to the low 
presence of ALA in most people’s diet, the anti-inflammatory outcome from D5D activity is 
almost negligible.   
The imbalance of ω6 to ω3 FAs may be part of the explanation of the significant rise of 
diseases like atherosclerosis, psoriasis, cancer, arthritis and chronic pulmonary diseases which 
are all associated with a condition called chronic low grade inflammation [13]. In acute 
inflammation, the inflammatory conditions will ideally terminate when the immune system 
has responded to and accomplished the damage. Chronic low grade inflammation on the other 
hand, may continue for year, decades or even a life time [14]. Chronic inflammation will be 
further discussed in section 2.4.3  
 
2.3 Cellular signaling pathways and gene control – an overview  
 
Cell signaling is a complex system where cells are able to respond to changes in the 
environment, and facilitate intracellular- and extracellular communication. Basically, 
signaling involves an interaction between a soluble molecule (ligand) and a cell membrane-
bound protein (receptor) (figure 2). There are an enormous number of different signaling 
pathways, and they typically get initiated when the ligand binds to its receptor inside or 
outside of the cell. A water soluble signal requires a receptor to transmit the message into the 
cell, while a membrane soluble ligand may diffuse through the cell membrane. When a ligand 
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binds to its specific receptor, it activates a series of events inside the cell. Intracellular 
enzymes like protein kinases and protein phosphatases are commonly found in signal 
pathways. Kinases and phosphatases activate certain transduction proteins in the signal 
cascade through phosphorylation and dephosphorylation respectively. Once an enzyme is 
activated, it may activate up to several downstream target enzymes and thereby amplify the 
intensity of a signal. The signal cascade will eventually result in protein synthesis, protein 
secreting, metabolism alterations or differentiation of the cell [15].  
 
Figure 2: Signal transduction. A ligand binds to its receptor and activates a signal cascade 
pathway. The signal may eventually activate a transcription factor and the initiation of 
protein synthesis [15]. Modified figure [15].  
 
The synthesis of a protein is a very complex and strictly regulated process. In brief, protein 
synthesis is initiated by transcription of nuclear DNA into messenger RNA (mRNA). The 
mRNA is translated into a polypeptide which ideally forms into a functional protein [15].  
The initiation of gene transcription requires proteins called transcription factors. Transcription 
factors are able to bind to specific DNA sequences (regulatory regions), to other transcription 
factors or even both. However, they all regulate the transcription of genes into mRNAs by 
either promoting or inhibiting the transcription process. The activity of a transcription factor 
is regulated at several levels; like all proteins, transcription factors are transcribed from a 
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chromosomal gene into an mRNA and translated from an mRNA into a protein. All these 
steps are strictly regulated, and the transcription factors may even regulate themselves by 
being their own repressor or activator. The translation of mRNA takes place in the cytoplasm, 
so the newly synthesized transcription factor needs to be transported into the nucleus where it 
promotes or inhibits the transcription of other genes. Several enzymes act to facilitate this 
relocalization through post-translational events such as phosphorylation, acetylation, 
methylation or ubiquitination. On the other hand, such modifications may also cause 
transportation out of the nucleus for some transcription factors, and thereby keeping them 
inactive (see section 2.6). The ability of DNA-binding or interactions with other transcription 
factors may also be regulated through such intracellular events. This multiple layer of 
regulation ensures a great specificity in the transcription of genes and production of proteins 
[16].  
 
2.4 Insulin, a hormone with multiple effects 
 
Insulin is a peptide hormone that regulates energy storage and the metabolism for fat and 
carbohydrates in the body. Insulin is secreted from the islet of Langerhans in pancreas at low 
levels on a continuous basis, but will increase in response to high blood glucose [17]. Secreted 
insulin stimulates the cellular uptake of glucose by facilitating the translocation of the 
intracellular glucose transporter GLUT4 to the cell surface [18]. Besides being a regulator for 
energy metabolism, insulin acts in the regulation of gene expressions and cell morphology 
alterations through several signaling pathways (Figure 3).  
 
2.4.1 Insulin activates the PI3-kinase/Akt pathway 
 
When insulin binds to the insulin receptor (IR) on the cell surface, it triggers the activation of 
at least nine intracellular substrates with different roles [19, 20]. The IR belongs to the 
tyrosine kinase receptors that catalyze the phosphorylation of its target proteins. Among these 
target substrates, four of them belong to the insulin-receptor substrate (IRS) family [19]. The 
phosphorylation of one of the IRS leads to an activation of phosphatidylinositol-3 kinase 
(PI3K), which has a major role in the insulin signaling. Activated PI3K will increase levels of 
phosphatidylinositol-3,4,5-triphosphate (PIP3), by phosphorylate phosphatidylinositol-4.5-
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biphosphate (PIP2). PIP3 can activate Akt, an important serine/threonine kinase. Akt plays a 
key role in the regulation of cellular growth and in the many responses to insulin [16]. 
Translocation of GLUT4 to the cell surface [21] and inhibition of the biological activity of 
transcription factor FOXO3A [22] as shown in figure 3, is two of many downstream events of 
Akt. The latter pathway is highlighted in blue, and will be discussed in section 2.6. 
 
Figure 3: Signaling pathways in response to insulin. The PI3-kinase/Akt pathway is 
highlighted in blue. Insulin binds to the insulin receptor (IR) which will activate 
phosphatidylinositol-3 kinase (PI3K) through insulin receptor substrate (IRS). Active PI3K 
leads to an increase in levels of phosphatidylinositol-3.4.5-triphosphate (PIP3), which 
activates Akt. Akt is translocated into the nucleus where it inhibits the activity of several 
transcription factors [16]. Modified figure [23].  
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2.4.2 Insulin and regulation of desaturases 
 
An important transcription factor induced by insulin is the sterol regulatory element binding 
transcription factor 1c (SREBP-1c). The binding site of SREBP-1c, the sterol regulatory 
element (SRE) has been reported in the promoter regions of D5D, D6D and SCD [24, 25]. 
Several reports have demonstrated how insulin affects transcription of desaturases; 
Experiments performed on rats showed an increase in expression of D5D, D6D and SCD as a 
response to insulin through SREBP-1c [25]. It has been suggested that insulin activates 
SREBP-1c through the PI3-kinase/Akt pathway [26]. More recently, Arbo et al demonstrated 
an induction in expression of the mentioned desaturases in human monocytes stimulated with 
insulin [27]. These findings illustrate how insulin might affect the metabolism of unsaturated 
fatty acids in mammals.  
 
2.4.3 Insulin resistance and chronic low grade inflammation 
 
As mentioned in section 2.2.3, some lifestyle diseases are strongly associated with chronic 
low-grade inflammation, a condition which may continue for several years [14]. The 
metabolic state that leads to an increase in expression of markers and mediators of chronic 
inflammation may also increase insulin resistance [28, 29]. Insulin resistance is a condition 
where the response to insulin is insufficient, which may lead to development of T2D [30]. 
How insulin resistance originates is not fully understood, but there is a link between insulin 
resistance and inflammatory processes. Inflammatory cytokines such as IL-1β and TNF-α 
may act as a mediator for insulin resistance by impairing the tyrosine kinase activity of IR and 
IRS, and thereby inhibit insulin signaling responses [31-33]. Chronic inflammation and 
insulin resistance are common in a numerous diseases like CVD, fatty liver diseases, 
dyslipidemia, hypertension, asthma and certain forms of cancer [34-36]. Obesity may trigger 
this type of condition as a response to excess nutrients and energy [37]. It has been estimated 
that every year, 35 million people will die due to chronic diseases. In fact, chronic 
inflammatory conditions are responsible for two thirds of global morbidity and about half of 
global deaths [13].  
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2.5 Cytokines –inflammatory agents 
 
The immune response is largely dependent on small regulatory proteins called cytokines. 
These molecules are released from a wide range of cells in order to modulate cellular 
responses important for inflammation.  Cytokines act through receptors on the surface of the 
target cell, and induce intracellular responses depending on cell type, environment and timing. 
[38].  
The cytokine tumor necrosis factor alpha (TNF-α) is known to be one of the major agents in 
the  inflammation process, and acts directly towards recovery from damage and destruction of 
tissues [39]. Induction of TNF-α will induce an inflammatory cascade and activate other 
inflammatory proteins where the injury or infection is located [39]. Although TNF-α has been 
shown to have an important therapeutic role, this cytokine have paradoxical features in 
relation to diseases: Due to the action of silent inflammation, TNF-α has been implicated in 
several diseases including ovarian cancer, neuroblastoma and AIDS [40-42].  TNF-α has been 
considered as a therapeutic agent in the treatment of cancer due to its ability to induce 
apoptosis in endothelium cells of tumor blood vessels [43, 44]. Later experiments have also 
shown some pro-cancer properties of TNF-α. Steps involved in tumorigenesis, including 
cellular transformation, proliferation and tumor promotion have all been linked to TNF-α [45-
47]. 
Another proinflammatory cytokine, interleukin-1 beta (IL-1β), affects almost every cell type 
by stabilizing mRNA or by initiating transcription of target genes [48]. IL-1β is mainly 
produced by macrophages and monocytes, but also by a variety of other cells [49]. Like TNF-
α, IL-1β stimulates a wide range of inflammatory and immune responses [50]. 
TNF-α and IL-1β are both responsible for the activation of the nuclear factor κB (NF-κB) 
[51]. NF-κB is a major transcription factor that regulates a wide range of genes involved in 
inflammatory processes. When TNF-α or IL-1β binds to specific receptors on the cell surface, 
it triggers the phosphorylation of IκB, an inhibitor of NF-κB. Phosphorylated IκB gets 
degraded through the ubiquitin system, and the free NF-κB is able to promote transcription of 
its target genes. Thus, incorrect regulation of NF-κB is associated with several inflammatory 
and autoimmune diseases [15].  
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2.6 FOXO3A  
 
FOXO transcription factors are members of the Forkhead family of proteins. These 
transcriptions factors have an important role in a variety of pathological and physiological 
processes, as they regulate the expression of several genes involved in development, 
differentiation, metabolism, cell growth and longevity [52-54]. In mammals, four members of 
the FOXO subgroup have been detected; FOXO1, FOXO2, FOXO3A and FOXO6 [55]. All 
FOXO proteins contain the characteristic Forkhead domain consisting of a 100-amino-acid, 
monomeric DNA-binding domain which folds up to a helix-turn-helix motif made up by three 
α helices and two large loops [56].  
FOXO3A (previously known as FKHRL1) has an important role in a variety of signaling 
pathways involved in apoptosis, cell cycle control, DNA repair, longevity and the immune 
system. As a transcription factor, FOXO3A acts to promote or inhibit expression of a wide 
range of genes. For instance, FOXO3A has been reported to induce a delay in the G2-M 
phase, and trigger DNA repair pathway through regulation of Gadd45a protein [54]. 
FOXO3A’s ability to control the cell cycle has also been shown in G1 and M-phase [57, 58].  
In mice FOXO3A has been reported to function as a NF-κB antagonist; FOXO3A 
overexpression was demonstrated to inhibit TNF-induced nuclear translocation of NF-κB, and 
thereby inhibit T-cell activity [59]. In the absence of FOXO3A, mice developed a 
spontaneous inflammatory syndrome associated with an increased NF-κB activity [59]. In 
neutrophilic inflammation however, FOXO3A is required to maintain the proinflammatory 
environment by suppressing neutrophilic apoptosis through inhibition of FASL [60]. 
Recently, the transcription factor Twist-related protein 1 (TWIST1) has attracted great 
attention due to its role in inflammation. TWIST1 activity has been reported to regulate 
expression and secretion of inflammatory adipokines (cytokines secreted by adipose tissue) in 
human white adipocytes [61]. Studies have also revealed a correlation between elevated 
TWIST1 levels and cancer metastasis [62]. Interestingly, FOXO3A has recently been reported 
to inhibit expression of TWIST1 in human bladder cancer cells, and thereby suppress 
urothelial cancer invasiveness [63]. Other reported FOXO3A downstream target genes 
include DNA-damage binding protein 1 (DDB1) [64], B cell translocation gene 1 (BTG1) [65, 
66], tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [67, 68], p130 [69] and 
Y box binding protein 1 (YBX1) [63].  
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FOXO proteins are strictly regulated in response to environmental conditions. The stability, 
subcellular location, gene target specificity of FOXO3A and its DNA binding activity are 
controlled by post-transcriptional modifications including methylation, phosphorylation, 
acetylation and ubiquitination [70]. As mentioned in section 2.4.1, activity of FOXO3A is 
regulated by Akt through the insulin/PI3K/Akt signaling pathway in response to insulin and 
growth factors (figure 4). FOXO3A is directly phosphorylated at three conserved residues by 
Akt. Phosphorylated FOXO3A binds to a protein called 14-3-3, which will lead to an export 
of FOXO3A from the nucleus and out in the cytoplasm [22, 71].  
 
Figure 4: regulation of FOXO transcription factors. Insulin and growth hormones activates 
the PI3K/Akt signaling pathway. Akt is translocated into the nucleus where it phosphorylates 
FOXO transcription factors on three conserved residues. Phosphorylated FOXO factors are 
recognized by 14-3-3 and translocated from nucleus into cytoplasm. In the absence of insulin 
and growth factor, FOXO transcription factors will continue the regulation of their target 
genes [71]. Figure [71].  
 
Although the post-transcriptional regulations of FOXO3A activity have been well 
investigated, the investigation of the regulation of FOXO3A mRNA expression has barely 
begun. During mRNA expression analysis, one must pay attention to the possibilities of 
presence pseudogenes. A pseudogene is a noncoding sequence sharing close similarity to a 
known gene present in the genome of an organism [72]. The first pseudogene was reported 
during investigation of the genome of Xenopus laevis in 1977 [73], and has subsequently been 
identified in bacteria, plants, insects and other vertebrates [74-76].  The nucleotide sequence 
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of a pseudogene differs from the coding gene at essential points as a result of gene 
duplication, either by retrotransposition or duplication of genomic DNA [72]. Initially, 
pseudogenes were considered to be nonfunctional. However, as some research groups have 
come across cases where pseudogenes may be involved in regulating transcription of other 
genes [77, 78], it has been suggested to establish a new term for pseudogenes that are 
involved in meaningful biological interactions. A pseudogene for FOXO3A has been found in 
humans located on chromosome 17, and is called FOXO3B [79]. 
 
2.7 Monocytes 
 
Monocytes are circulating blood cells with essential roles in the innate immune system of 
humans. In line with all blood cells, monocytes arise from hematopoetic stem cells located in 
the bone marrow. Promonocytes, developed from granulocyte-monocyte progenitors in the 
bone marrow, enter the bloodstream and differentiate into mature monocytes. In response to 
an inflammatory signal, monocytes are able to move quickly to the site of infection to elicit an 
immune response. They circulate and enlarge in the bloodstream for about 8 hours, before 
migrating into infected tissues and differentiate into macrophages [80]. 
 
2.7.1 The monocytic cell line THP-1  
 
Investigations of the function and features of human monocytes in the cardiovascular system 
are often performed in THP-1 monocytes. The monocytic cell line THP-1 is derived from the 
blood of a human male with acute monocytic leukemia. As these cells are cultured in vitro 
there are certain required condition factors that need to be fulfilled: A temperature at 37 °C 
and a gas mixture at 5 % CO2 are good conditions for achieving cell growth [81]. THP-1 cells 
have an average doubling time at 35 to 50 hours, and should be kept in cultures of minimum 
2x10
5
 cells/mL and not more than 1x10
6
. Recommended medium is the RPMI1640 and 10% 
fetal bovine serum (FBS).  
Cells usually grow in a standard pattern of growth consisting of three phases; lag phase, log 
phase and plateau phase. During the lag phase there is minor growth or no growth at all. This 
is the first phase after subculture, and the cells need some time to adapt to the medium. The 
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cells are in its most reproducible condition during the log-phase. Here, the cells are in 
exponential growth, until they reach the plateau phase where cell growth is more or less equal 
to cell death. Adhesive monolayer cells will stop dividing when they reach a saturated 
density, due to the contact with other cells. Suspension cells, such as THP-1 do not 
necessarily show the same plateau in growth, but will eventually reach this phase due to 
exhausting of the medium. Prior to experiments, cells should be in the log-phase where the 
growth fraction is high [82]. 
During log-phase THP-1 cells are randomly distributed in the cell cycle. Prior to any 
experiments, the cells should be synchronized [82]. This can be done by restricting the growth 
and manage the cells “out of cycle”, a state called G0. Previous research showed that THP-1 
cells kept in 0.5% Fetal calf serum (FCS) for 16 hours prior to the experiment, revealed a 
significantly higher expression of desaturases (D5D, D6D and SCD) compared to cells kept in 
10% FCS [27]. 
THP-1 cells are one of the most widely used cell lines to investigate the regulation and 
function of monocytes and macrophages. Several reposts have demonstrated that this cell line 
is suitable for mimicking human monocytes in inflammation-and diabetes-related studies [83, 
84]. However, it is important to know that THP-1 cells and circulating monocytes do have 
some significant differences [84]. Careful consideration is therefore needed when results are 
generalized to monocytes and macrophages.  
 
2.7.2 Passage number 
 
The cell line THP-1 can provide continuous culture, which means that they are able to be 
propagated in vitro for an indefinite time. However, subculturing may change the properties 
of a cell line over time. The degree of subculturing is often expressed as “passage number” It 
has been demonstrated that a high passage number may influence cell morphology, growth 
rate and gene expression compared to cells with a low passage number [85, 86]. The aging 
effect is cell type dependent, and has been shown to have a variable impact on different genes 
[86]. Continuous cell lines are widely used as research tools, and the quality of the cell line is 
crucial to obtain successful experiments. To ensure reproducible and reliable results, it is 
important to use cells with a low passage number and pay attention to any alteration over 
time.  
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2.8 Quantitative real-time PCR (qPCR) 
 
The regulation of gene expression makes it possible for an organism to adapt to variable 
conditions and stimuli, such as exposure to hormones or cytokines [87, 88]. These changes in 
levels of expressed genes may be analyzed by a variant of polymerase chain reaction (PCR) 
called quantitative real-time polymerase chain reaction (qPCR). qPCR is a sensitive and 
precise method where complementary DNA (cDNA) synthesized from total RNA, is used as 
template for the amplification reactions. This method is based on detections of fluorescence 
signals from a reporter molecule, which will increase during each cycle of cDNA 
amplification. A quantitative threshold for the DNA-based signal to be detected is set just 
above the background. The quantitative cycle (Cq) is defined as the number of cycles needed 
for the fluorescence signal to reach a fixed threshold, and represent the amount of target gene 
in the sample [89]. 
As the amount of RNA added to the reverse transcript reaction may vary, the PCR reaction 
needs to be normalized by a suitable reference gene. Ideally, a reference gene should be 
unaffected by the experimental procedure [89]. Several housekeeping genes, like GAPH, β-
actin, β2-microglobulin and rRNA have been used for this purpose, but it has been reported 
that these genes may be influenced by various experimental settings [90]. Therefore, the 
selection of an appropriate reference gene should be done prior to qPCR analysis.  
 
2.9 Primer design 
 
Prior to any qPCR analyses, it is essential to choose a suitable primer pair to achieve 
successful amplification of a target gene. When designing primers it is important to check 
them for specificity to avoid amplification of other genes with similar sequence. NCBI’s 
Primer BLAST (Nucleotide Basic Local Alignment Search Tool) is a useful tool during 
primer selection.  
Primer BLAST uses Primer3 [91] to design PCR primers and then submits them to a BLAST 
search against the GenBank database to ensure specificity. BLAST also allows the primer pair 
to be complementary to each side of an intron on the DNA sequence, in order to distinguish 
between amplification of genomic DNA and cDNA. The primer 3 software makes it possible 
to select options like product size and annealing temperature (Tm). Such factors are important 
  2. Introduction 
21 
 
to consider as certain guidelines needs to followed when designing primer pairs [92] ; Each 
primer should consist of 18-25 bases, where 40-60% of these should include the bases 
cytosine (G) an guanine (C). The primer sequence end should not contain 3 or more Cs or Gs, 
but should end with a G/C/GC or CG. To avoid the synthesis primer diming, the 3’ends 
should be uncomplimentary and self-complementary primers must be excluded. Finally, the 
Tm should be between 55-80 °C [92].  
To evaluate the qPCR products given by the primer pairs, analyses of the dissociation curve 
data can be very useful. Products from the amplification should have the same melting point, 
which can be seen as a single, sharp peak at the melting temperature of the amplicon. If the 
dissociation curve reveals a series of different peaks, the discrimination between specific and 
non-specific products are not sufficient [93]. In addition, qPCR products may be evaluated by 
gel-electrophoresis. If the qPCR results in one product per primer pair and product size 
correspond to an expected length, the primer pair is considered as suitable.   
 
2.10 The 2
-ΔΔCq
 Method 
 
Data from quantitative qPCR analyses may be calculated by the 2
-ΔΔCq
 method in order to 
analyze relative changes in gene expression.  
First, the average Cq value is calculated for each target- and reference gene. The average Cq 
value is further used to find ΔCq, where ΔCq = Cq target gene - Cq reference gene. The ΔΔCq is 
calculated from ΔCq sample x - ΔCq control, which is used to find 2
-ΔΔCq
 [89] 
The fold change of expression of the target gene in treated samples relative to the untreated 
samples (control) is indicated by the evaluation of 2
-ΔΔCq
 [89].  
A prerequisite for the 2
- ΔΔCq
 method is that the target gene and the reference gene should have 
similar amplification efficiency. The efficiency may be evaluated by investigating the ΔCq 
using various cDNA dilutions. When ΔCq-values are plotted against log cDNA dilutions, the 
slope of regression line should be close to zero [89].  
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2.11 Aims of thesis 
 
Recently, a human intervention study was performed in order to investigate changes in gene 
expression in response to nutrient composition [94]. Microarray analyses revealed diet-
specific changes in leukocyte gene expression when slightly overweight individuals went 
through diets with different carbohydrate fraction relative to fat and protein. A diet with a 
reduced amount of carbohydrates seemed to reduce processes associated with chronic 
inflammation compared to a high carbohydrate diet relative to protein and fat. Among several 
findings, an upregulation of FOXO3A mRNA expression was reported in the diet with a 
reduced fraction of carbohydrates relative to protein and fat.  
At the same time the group demonstrated an upregulation in the fatty acids desaturases D5D, 
D6D and SCD mRNA expression in THP-1 monocytes treated with insulin [27]. These 
findings demonstrated that THP-1 monocytes may work well as a model-system for 
circulating blood cells in the study of nutrients responses in vitro.  
The aim of this thesis is to investigate the regulation of gene expression related to 
inflammation in response to insulin and/or cytokines in THP- monocytes. The main focus is to 
reproduce the regulative insulin-effect on desaturases expression that was recently shown in 
THP-1 cells by Arbo et al [27], and to investigate potential regulating effects of insulin 
related to FOXO3A mRNA expression. Furthermore, it is of interest to look at mRNA 
expression levels of FOXO3A and desaturases in response to cytokines, and the effect of 
insulin in combination with cytokines. Finally, expression levels of FOXO3A target genes are 
investigated in order to demonstrate potential effects of insulin, cytokines and the 
combination of insulin and cytokines. In addition, the following secondary objectives were 
included: 
-Optimization of qPCR parameters  
-Designing and evaluate relevant primers 
-Choosing suitable reference genes 
-Determine the cell concentration at which the THP-1 cells should be during the experiments  
-Investigation of responsiveness in low-passage and high-passage THP-1 monocytes 
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3. MATERIAL AND METHODS 
 
3.1 Reagents 
 
Information about essential reagents used in the current study can be found in table 1.  
Table 1: Reagents are presented with lot number and provider. 
 
Materials 
 
 
Provider 
 
Lot number 
6x Orange Loading  Dye Solution Fermentas 0802 
Agarose Sigma 059K0033 
Deoxyribonucleotide triphosphate (dNTPs) Sigma Aldrich 011M0489 
Distilled Water (dH2O), DNase/RNase Free Gibco/Invitrogen 722035 
Dithiothreito (DTT) Invitrogen 1009479 
DNA ladder (100 bp) Promega 24974001 
Fetal Bovine Serum Gibco 41G5893P 
Gel red  Biotium 10G0428 
Gentamicin Sigma Aldrich 031M0851 
Insulin solution, human recombinant Sigma Aldrich 011M8410 
Interleukin-1 Beta (IL-1β) Roche 131926000 
L-glutamin Sigma Aldrich F7524 
Moloney Murine Leukemia Virus Reverse Transcription 
(M-MuLV RT) 
Invitrogen 1102594 
Random Hexamer Primer Promega 0000001274 
Recombinant RNasin Ribonuclease inhibitor (RNasin) Promega 29458001 
RNA isolation kit; RNeasy Mini Kit Qiagen N/A 
RPMI 1640-medium Sigma Aldrich RNBB6748 
SYBR-green Jump Start Taq Redy Mix Sigma Aldrich N/A 
Tumor necrosis factor alpha (TNF-α) R&D systems N/A 
β-mercaptoetanol  Sigma Aldrich N/A 
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3.2 Cell culture 
 
3.2.1 Cell cultivation 
 
All experiments were performed on human monocytes from the monocytic cell line THP-1 
(American Type Culture Collection, Manassas, VA, Catalog No. TIB-202). The concentration 
of cells was kept under 1 x 10
6
 at all-time by subculturing the cells to 2 x 10
5
 cells/mL every 
3
rd
-4
th
 day. Cells were grown in suspension of RPMI-1640 medium supplemented with heat-
inactivated 10 % fetal bovine serum (FBS), 0.002 % gentamicin, 1 % L-glutamine and 0.05 
mM β-mercaptoetanol. To ensure optimal conditions for achieving cell growth, the THP-1 
cells were cultured in tissue culture flask at 37˚C in 5 % CO2.  
 
3.2.2 Freezing and thawing of cells  
 
After a certain number of passages, the shape and properties of THP-1 cells may be altered 
[82]. In order to keep the passage number to a similar level during the experiments, cells were 
frozen in suspension with cryoprotectant dimethylsulfoxide (DMSO) at -80°C. DMSO was 
used to slow down the cooling rate and reduce the formation of ice crystal inside the cell [82]. 
 The frozen cells suspension were thawed on water bath holding 37°C, and supplemented with 
10% RPMI medium (10 mL, 37°C). The DMSO-medium was replaced with 10 mL preheated 
RPMI medium after centrifugation (700 rpm, 5min) of the cells. Cells were placed in a 25 cm
2
 
tissue flask, and incubated at 37°C in 5% CO2 for 24 hours. To remove all remains of the 
DMSO, the cells were centrifuged and resuspended in preheated RPMI medium the next day. 
After 3 days, the cells were once again resuspended to 2x10
5
 cells/mL and cultured as normal.   
 
3.2.3 Stimulation of THP-1 monocytes  
 
Prior to all experiments, cells were subcultured to 3x10
5
 cells/mL and grown in 10 % serum. 
Then, within the next 2-3 days the cells were grown to a concentration of ~6x10
5
 cells/mL, 
centrifuged (700 rpm, 5min) and resuspended in 0.5% FBS for serum starvation. The cells 
were starved in 0.5% FBS for 16 hours prior to the various treatments. 
  3. Materials and methods 
25 
 
Cells were stimulated with human recombinant insulin (0.01 µM), human IL-1β (10 ng/mL) 
and human TNF-α (10 ng/mL) in 0.5% FBS. The concentrations of IL-1β and TNF-α that 
were chosen were based on previous research [95-97]. Dose dependent experiments were 
performed in order to find the optimal concentration of insulin. The various insulin 
concentrations were chosen based on previous research [27]. To optimize the period of 
treatment, time-course experiments were performed for all the listed stimulation factors and 
for the different target genes.  
 
3.3 Isolation of total RNA 
 
Qiagen RNeasy Mini kit was used to isolate total RNA from THP-1 monocytes, in accordance 
with the manufacturer’s instructions [98]. Only RNA of high quality (A260/A280>2, 
A260/A230>1.8) was used for further analysis. The quality and quantity (ng/µL) of RNA 
were measured by using Nanodrop ND-1000 Spectrophotometer (NanoDrop®).  Samples of 
RNA were always kept on ice during experiments in order to prevent degradation. The RNA 
samples were stored at -80°C between the analyses. 
 
3.4 cDNA synthesis from total-RNA 
 
1 µg of total RNA was used for each first strand complementary DNA (cDNA) synthesis. 
Distilled water was added to the RNA to adjust the volume to a total of 9 µL. A mix of 
reagents containing 5x First strand buffer (4 µL), DTT (10 mM, 2 µL), dNTP (10 mM, 2 µL), 
Random hexamer primer (100 µg/mL, 1 µL) and M-MuLV-RT (1 µL) was made for each 
sample of RNA/dH2O. After adding the mix of reagents, the samples were incubated at 25°C 
for 10 minutes to start a primer extension, then at 37 °C for 1 hour for first strand synthesis 
and finally at 95°C for 5 minutes to obtain a reaction termination. The cDNA was diluted 1:6 
with ultra-pure water, and stored at -20°C for further analysis.  
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3.5 Primers for qPCR 
 
Primers for D5D, D6D and SCD were chosen based on previous research [99, 100], while 
primers for FOXO3A, BTG1, DDB1, TRAIL, P130 and TWIST1, YBX1 were all designed 
according to guidelines described in section 2.9 with the assistance from Sigma Aldrich. 
Oligoname and sequences for each primer pairs are listed in table 2. A Primer BLAST search 
was performed for all primers to confirm gene specificity. 
Table 2: Oligoname and sequences for primer pairs. The underlined G in reverse primer for 
D6D is different from the sequence of Cho et al.[99]. The correct base should be a G as 
shown here, according to the sequence of accession number AF126799. 
Oligoname Forward primer Reverse primer 
 
BTG1 CTGGCACAAGATAGAATGGTAA ACTTGGACTCACAGGCTAT 
D5D GAATAAAGAGCTGACAGATGAG CCTGAACTGCACTGAGCA 
D6D GGCAAGAACTCAAAGATCAC GAGAGGTAGCAAGGACAAAG 
DDB1 GTCACTCTCAAGGATCTC AACACAACACCATTATCAAG 
FOXO3A AGGAAGGGGAAGTGGGCAAAGC TGCTGGTTAGGAAAATGGCGTGG 
P130 TTGCTAACAGACTGAAAGA GCTCAATAACAGATTCTAATACT 
SCD ATCTCTAGCTCCTATACCACC CCCAAAGCCAGGTGTAGAAC 
TRAIL TCAGGATGATACACTATGAAGATG GTTGTGGCTGCTCTACTC 
TWIST1 ACCATCCTCACACCTCTG GATTGGCACGACCTCTTG 
YBX1 CTTACCATCTCTACCATCAT AGCACTTTAGGTCTTCAG 
 
 
3.6 qPCR  
 
Fluorescence-based qPCR analyses were performed for all the genes of interest on a 
Mx3000P instrument (Stratagene, La Jolla, CA, USA). All the reactions contained 5 µL 
cDNA diluted 1:6, 0.3 µM of forward and reverse primer and 12.5 µL SYBR®Green 
JumpStart Taq ReadyMix (0.4 mM of each dNTP, 20 mM Tris-HCl (pH 8.3), 100 nM KCl, 7 
mM MgCl2, 0,05 U/µL Taq DNA polymerase, JumpStart antibody, SYBR green 1 dye and 
stabilizers). Ultra-pure water was added to adjust the volume to a total of 25µL.  
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The cycling program of Mx3000P started at 95°C for 3 minutes to initiate a denaturation step, 
followed by 40 cycles of 95°C for 30 seconds, 60°C (65°C for FOXO3A) for 30 seconds and 
finally 72°C for 30 seconds to perform denaturation, annealing and extension respectively. 
Mx Pro
TM
 Q-PCR Software (Stratagene, La Jolla, CA, USA) were used to analyze the data. 
 
3.7 Gel-electrophoresis  
 
The products from the qPCR reaction were separated and visualized by gel electrophoresis. 
The products were run on a 3% agarose gel, made up by agarose diluted to a 3% 
concentration in 1 x TAE buffer (a mixture of Tris base, acetic acid and EDTA). GelRed
TM
 
DNA stain were added to the agarose solution (1:10 000). Bands were visualized by UV light 
on a Molecular Imager gel Doc XR System (BioRad), and compared to a 100 bp DNA ladder. 
 
3.8 Calculations and Statistical analysis 
 
The 2
-ΔΔCq
 method was used to analyze the gene expression data from the qPCR experiments 
for all genes.  
Paired, two-tailed Student T-test was used to compare the mean of the ΔCq-value for treated 
cells with the ΔCq-value for untreated cells (control) in relation to the variation in the data.  
A difference between groups of p<0.05 was considered as significant. When several T-tests 
are being performed, the probability that the result of a test is random will increase. The 
Bonferroni correction is a method used to counteract this problem. It simply divides the p-
value on the number of independent experiments performed. P-values for the T-tests 
performed in this study are presented in the Appendix.  
Since the T-test requires data to be approximately normally distributed, the 2
-ΔΔCq
 values were 
log-transformed. This is common a practice in analyses of mRNA gene expression data.  
To present the differences in treated- and untreated THP-1 cells as fold change, ΔΔCq was 
transformed to 2
-ΔΔCq
, where the control is set to the value 1.0.
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4 RESULTS 
4.1 Optimization of the qPCR parameters  
 
4.1.1 Validation of primers 
 
In this study, quantitative PCR (qPCR) were used to detect the mRNA expression of selected 
genes. This method requires optimization of certain parameters in order to obtain successful 
results, including the validation of selected primer pairs. As mentioned in section 2.9, the 
dissociation curve from qPCR can be useful to ensure that the amplicon of interest is detected.  
The dissociation curve was examined for each primer pair after every qPCR to exclude 
primer-dimer, contaminating DNA and qPCR products from misannealed primers. When 
primers for FOXO3A were added to 12 separate samples of cDNA, the resulting dissociation 
curves from qPCR revealed a single peak at the melting temperature for the FOXO3A 
amplicon (figure 5). This was also observed for all the primers used in this study (not shown).  
 
Figure 5: Dissociation curve for qPCR product from 12 samples with primers for FOXO3A. 
Taken together, all 12 samples results in a single peak at the melting temperature for the 
amplicon, which reveals a pure and correct amplification.  
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4.1.2 Finding the optimal primer concentration for qPCR 
 
The optimization of the primers is essential as each set of primers are most efficient under 
different conditions. Primer concentrations need to be optimized to ensure an accurate and 
specific qPCR reaction. The primer concentration in the amplification reaction should be 
somewhere between 0.1 and 0.5 µM [101].  
Primer concentrations of 0.2 µM, 0.3 µM and 0.4 µM were validated to find the most efficient 
concentration for qPCR. cDNA from 1 µg total RNA isolated from non-stimulated THP-1 
monocytes was used as template for the reaction. The amplification plots were compared and 
the FOXO3A primer concentration that gave the lowest Cq-value, 0.3 µM, was chosen for 
qPCR (figure 6).  
 Figure 6: Validation of primer concentration for FOXO3A: Amplification plots and Cq-
values from a qPCR reaction with various concentrations of primers for FOXO3A (0.2 µM, 
0.3 µM and 0.4 µM).  
 
Even though there was only a small difference in the Cq-value between the three 
concentrations, 0.3 µM was selected as the primer concentration for further experiments. 0.3 
µM was also selected as the proper concentration for the same primer pairs used in previous 
study of D5D, D6D and SCD mRNA expression [27]. Consequently, this primer 
concentration was selected for all target genes in current study. 
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4.1.3 Visualization of qPCR products 
 
As different cells may express different sets of genes and due to the fact that a primer pair 
may recognize more than one target gene, it was desirable to ensure that the templates used 
for qPCR were indeed the genes of interests. Products from qPCR were separated on a 1.5% 
agarose gel and visualized with UV-light after staining with GelRed (figure 7). A 100-bp 
DNA ladder was used to indicate the sizes of the different qPCR products. Single, clear bands 
visualized on the three separate gels in figure 7 indicate pure qPCR products. The size of the 
fragments was verified based on the DNA ladder, and they all revealed bands with expected 
sizes. FOXO3A, D5D, D6D, SCD, DDB1, TRAIL, BTG1 and TWIST1 were therefore 
considered as expressed in THP-1 monocytes. Neither P130 nor YBX1 were detected by 
qPCR, and were therefore excluded in further experiments.           
 
     
Figure 7: Products form the qPCR with primers for the target genes. Gel electrophoresis (3% 
agarose gel) was used to separate the products after qPCR amplification, and bands were 
visualized by UV-light. The molecular weight standard (MwSt) indicates a marker lane to the 
left where DNA fragments with a known base pair (bp) size are visualized and can be 
compared with the qPCR products with primers for D5D (202 bp), D6D (167 bp), SCD (283 
bp), FOXO3A (148 bp), DDB1 (86 bp), TRAIL (107 bp), BTG1 (105 bp) and TWIST1(132 
bp). 
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4.1.4 Finding a suitable reference gene 
 
There is a challenge associated with qPCR; the uncertainty about the precise amount of 
amplifiable cDNA present in the reaction. As described in section 2.10, this can be solved by 
amplifying a second gene used as a reference gene [89]. Four genes were selected as potential 
reference genes for this study; Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Beta-
2-microglobulin (B2M), Hypoxanthine phosphoribosyl-transferase I (HPRT1) and 18S 
ribosomal RNA (18s rRNA). When the ΔΔCq method is being used to analyze relative 
changes in gene expression, the amplification efficiency between the target and the reference 
gene should be similar (section 2.10) [89].  The amplification efficiency was determined for 
all target genes.  
cDNA from 1 µg of total RNA isolated from untreated THP-1 cells were diluted over a 1000 
fold range and used as template for the qPCR. qPCR were performed for each dilution, with 
primers for the target genes and the reference genes. ΔCq was calculated for each reference 
gene compared to every target gene, and plotted against log cDNA dilution. The ΔΔCq 
method can be used to analyze changes in gene expression only if the absolute value of the 
slope is close to zero.  
GAPDH, 18sRNA, B2M and HRTP were all suitable reference genes for D6D mRNA 
expression analysis according to the amplification efficiency test (figure 8). Due to biological 
and technical reasons (discussed in section 5.2), 18s rRNA was chosen as reference gene for 
further experiments. 18s rRNA was also considered to be a suitable reference gene for D5D, 
SCD, FOXO3A and TRAIL (not shown).  
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Figure 8: Slop of the regression lines for D6D compared to potential reference genes. The 
efficiency of amplification of D6D and potential reference genes (18s rRNA, B2M, HRTP and 
GAPDH) was evaluated using qPCR. cDNA diluted over a 1000 fold range (where the most 
concentrated sample was diluted 1:2)  from 1 µg RNA was used as template for the qPCR. 
The resulting ΔCq was calculated for D6D and each reference gene and plotted against 
cDNA dilution.  
 
4.2 Cell growth of THP-1 monocytes 
 
Prior to the experiments it was of interest to study the growth of the THP-1 monocytes, as the 
properties of a cell culture vary between lag, log and the plateau phase. Consequently, the 
relationship between cell state and cell number was investigated. THP-1 cells were 
subcultured in three different culture tissue flasks with an initial number of 1.5x10
5
, 2.0x10
5
 
and 2.5x10
5
 cells/mL. Cell number was counted on a Bürker counting chamber every 24
th
 
hours for 6 days without replacing the medium. Cell numbers from the three different culture 
tissue flasks were plotted against time to illustrate a growth curve (figure 9). THP-1 cells that 
were subcultured to 2.5x10
5
 cells/mL went immediately to the log-phase, while cells with an 
initial concentration of 1.5x10
5
 and 2x10
5
 cells/mL were in the lag-phase the first 24 hours. A 
plateau phase can be observed when the cells reach a concentration of 7-8x10
5
 cells/mL. Cells 
for experimental use should be taken in late log phase to ensure that cells are in a proliferative 
state before serum starvation.  As mentioned in section 2.7.1, THP-1 cells should never 
exceed 1 x 10
6
 cells/ml in order to ensure exponential growth [81]. Consequently, cells used 
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in further experiments were always on a concentration of ~6x10
5
 cells/mL during serum 
starvation, and hence 7-8x10
5
 cells/mL during stimulation.  
 
 
Figure 9: Determination of cell growth and cell state. THP-1 cells were subcultured to a 
concentration of 1.5x10
5
, 2.0x10
5
 and 2.5x10
5
 per mL in RPMI medium with 10% FBS. The 
cell number was counted every 24
th
 hour for 6 days and plotted against time. The arrow 
indicates the cell concentration that was used in further experiments (late log-phase). 
 
 
4.3 D5D, D6D and SCD gene expression is regulated by insulin 
 
4.3.1 Expression of desaturases is dose-dependently regulated by insulin in THP-1 
monocytes. 
 
The enzymes delta-5-desaturase (D5D), Delta-6-desaturase (D6D) and stearoyl-CoA 
desaturase (SCD) participate in the biosynthesis of PUFAs in humans [6, 9]. Recently, 
nutrient composition has been suggested to influences the transcription of these desaturases as 
mRNA expression has been reported to increase in response to insulin [27, 102-104]. In these 
former experiments, different concentrations of insulin were used to demonstrate this 
regulative effect.  
In order to optimize in vitro conditions for studying alterations in desaturase mRNA 
expression in response to insulin in THP-1 monocytes, a series of dose-response experiments 
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was performed. THP-1 cells were treated with various concentrations of insulin (0.1 µM, 1 
µM, 10 µM, 100 µM and 1000 µM) chosen based on concentrations used in Arbo et al [27].  
THP-1 cells treated with 0.1 µM insulin seemed to be more responsive compared to cells 
treated with higher insulin concentrations. Consequently, it was of interest to investigate the 
regulation of desaturase mRNA expression in response to insulin concentrations beneath 0.1 
µM.  
Consequently, the next experiment included a minimum concentration of 0.001 µM insulin. 
Results from these experiments indicated that 0.01, 0.1 and 1 µM insulin were all good 
inducers for desaturases mRNA expression in THP-1 cells (figure 10). The experiment was 
repeated and resulted in similar observations (not shown). 0.01 µM insulin was used to 
investigate changes in expression of D5D, D6D and SCD in further experiments as this 
concentration also seemed to induce regulation of FOXO3A mRNA expression (see section 
4.4.1).  
A time-course experiment was performed in order to verify that the 24-hours treatment period 
chosen based on previous work [27, 102-105] was optimal for inducing desaturase expression. 
THP-1 cells were treated with insulin for several treatment periods (2, 4, 8, 12, 24, 48, 72 
hours). Cells treated with insulin for 24 hours were indeed more responsive than cells treated 
for a longer or shorter period (not shown). Consequently, THP-1 cells were treated with 
insulin for 24 hours in further experiments in order to investigate regulation of D5D, D6D and 
SCD mRNA expressions induced by insulin.   
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Figure 10: Fold change of D5D, D6D and SCD mRNA expression compared to control (0). 
THP-1 cells (29 passages) were stimulated with indicated concentrations of insulin in 0.5% 
FBS for 24 hours after serum starvation (0.5% FBS, 16 hours). Expression of D5D, D6D and 
SCD is normalized with 18s rRNA, and fold change for each gene is calculated by the 2-ΔΔCq 
method. The experiment were repeated and revealed similar results.  
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4.3.2 D5D, D6D and SCD gene expression is significantly up-regulated by insulin  
 
THP-1 cells stimulated with insulin for 24 hours reveal a significant up-regulation in 
desaturase mRNA expression (figure 11). The mean fold change of D5D, D6D and SCD 
mRNA expression between insulin-treated and untreated THP-1 cells is 2.1, 1.7 and 2.2 
respectively. These results are based on four independent experiments. 
 
 
 
Figure 11: mRNA expression of D5D, D6D and SCD in THP-1 cells is significantly 
upregulated in response to insulin. THP-1 cells (passage number < 40) were stimulated with 
insulin (0.01 µM) in 0.5% FBS for 24 hours after serum starvation (0.5% FBS, 16 hours). 
Expression of D5D, D6D and SCD is normalized with 18s rRNA. The fold change between 
treated and untreated cells (control) is calculated by the 2
-ΔΔCq
 method and represents the 
mean of four independent experiments. * indicates a significant difference (p<0.013) after a 
Bonferroni correction, based on a two-tailed t-test. Error bars show a 95% confidence 
interval for the true values of the fold change.  
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4.3.3 Desaturases and cytokines 
 
Regulation of the fatty acid desaturases D5D, D6D and SCD is important for a range of 
cellular functions including the process of inflammation, as they catalyze the metabolism of 
several pro- and anti-inflammatory agents [11, 12]. As IL-1β and TNF-α have important roles 
in the inflammatory process, it was of interest to investigate D5D, D6D and SCD mRNA 
expressions levels in THP-1 cells stimulated with these cytokines. THP-1 cells were also 
treated with IL-1β and TNF-α in combination with insulin, to reveal any cooperative effect.  
THP-1 cells were treated with IL-1β, TNF-α, insulin and insulin combined with IL-1β and 
TNF-α for 24 hours. Two sets of cDNA were synthesized from total RNA representing each 
experimental condition and used as template for qPCR with primers for D5D, D6D, SCD and 
18s rRNA. Untreated THP-1 cells were used as control.  
THP-1 cells treated with IL-1β show a tendency of up-regulation in D5D, D6D and SCD 
mRNA expression compared to untreated cells (figure 12). Elevated mRNA expression of 
D5D, D6D and SCD can also be seen in TNF-α-treated cells. However, the clearest induction 
in D5D and SCD mRNA expression is observed in insulin-treated THP-1 cell, while mRNA 
expression of D6D shows similar responsiveness to all treatments. Regarding THP-1 cells 
treated with a combination of the three stimulating factors, an increased mRNA expression of 
D5D, D6D and SCD can be seen compared to untreated cells.  However, cells treated with IL-
1β, TNF-α and insulin did not show any cooperative effects for desaturase mRNA expression.  
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Figure 12: Fold change of desaturases compared to control. THP-1 cells (13 passages) were 
stimulated with IL-1β (10 ng/mL), TNF-α (10 ng/mL) and insulin (0.01 µM) and combinations 
for 24 hours after serum starvation (0.5% FBS, 16 hours). mRNA expression is normalized 
with 18s rRNA, and the fold change for each gene is calculated by the 2
-ΔΔCq
 method. Error 
bars represent SD for two different cDNA syntheses to illustrate technical variances.  
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Furthermore, we wanted to investigate the combination of insulin and cytokines. THP-1 cells 
were treated with the same stimulation factors as in the previous experiment, but this 
experiment also included THP-1 cells treated with a combination of IL-1β and TNF-α without 
insulin, and insulin combined with each one of the cytokines.  
Cells stimulated with IL-1β revealed only a slight up-regulation in D5D and D6D mRNA 
expression compared to untreated cells (figure 13). mRNA expression levels of SCD seemed 
to be unaffected by IL-1β, as only a negligible increase can be observed. mRNA expression of 
D5D and D6D in response to TNF-α were elevated compared to untreated cells, while SCD 
mRNA expression seemed to be slightly down-regulated. Regarding the different 
combinations, none of the cells that were treated with the various combinations gave a more 
elevated expression of desaturases than insulin alone. In general, THP-1 cells were less 
responsive to the treatments in this experiment compared to the previous experiment. A 
possible explanation for this behavior will be illustrated in section 4.6.   
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Figure 13: Fold change of D5D, D6D and SCD mRNA expression compared to control. THP-
1 cells (46 passages) were stimulated with IL-1β (10 ng/mL), TNF-α (10 ng/mL), insulin (0.01 
µM) and listed combinations in 0.5% FBS for 24 hours after serum starvation (0.5% FBS, 16 
hours). Expression of D5D, D6D and SCD is normalized with 18s rRNA, and the fold change 
for each gene is calculated by the 2
-ΔΔCq
 method. The error bars represent the SD for two 
different cDNA syntheses to illustrate technical variances. 
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4.4 FOXO3A 
 
The biological activity of transcription factor FOXO3A is tightly regulated by several 
modifications, including methylation, acetylation, ubiquitination and phosphorylation [70]. 
FOXO3A has been reported to be regulated by Akt through the insulin/PI3K/Akt signaling 
pathway in response to insulin and growth factors [22]. In accordance to this, a suppression of 
FOXO3A activity has recently been demonstrated in THP-1 cells cultured in high glucose-
conditions [106]. The molecular mechanisms regulating the transcription of FOXO3A gene 
remain mostly unclear, but an increase in transcription has been reported in the liver from rats 
after 48 hours of fasting [107]. Moreover, investigations of diet-specific changes in leukocyte 
gene expression reported an upregulation in FOXO3A mRNA in response to a reduction in 
diet carbohydrate quantity relative to protein and fat [94]. Due to these observations it was of 
interest to investigate if insulin could be involved in the regulation of FOXO3A mRNA 
expression.  
Next, expression of FOXO3A mRNA is analyzed in THP-1 monocytes treated with insulin 
and proinflammatory cytokines, in order to reveal any relation to the glucose metabolism and 
inflammatory-related processes. 
 
4.4.1 Expression of FOXO3A is dose-dependently regulated by insulin in THP-1 
monocytes 
 
In order to find the optimal insulin concentration for the investigation of the regulation of 
FOXO3A mRNA expression, cDNA from the three dose-response experiments described in 
section 4.3.1 were used as templates for the qPCR.  
The gene expression of FOXO3A was unaffected in insulin-treated THP-1 cells in the first 
(0.1 µM, 1 µM, 10 µM and 100 µM insulin) and the third (0.001 µM, 0.01 µM, 0.1 µM, 1 
µM, 10 µM and 100 µM insulin) set of experiments (data not shown). Analyses of the second 
experiment (0.001 µM, 0.01 µM, 0.1 µM, 1 µM, 10 µM and 100 µM insulin) demonstrated a 
regulation in FOXO3A mRNA expression in THP-1 cells that were treated with 10 µM and 
0.01 µM insulin for 24 hours (figure 14). As FOXO3A mRNA expression seemed slightly 
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more affected in cells treated with 0.01 µM, and the desaturases seemed to be responsive to 
this concentration as well, 0.01 µM insulin was used for further experiments. 
 
 
Figure 14: Fold change of FOXO3A mRNA expressions compared to control (0). THP-1 cells 
(28 passages) were incubated with the listed concentrations of insulin in 0.5% FBS for 24 
hours after serum starvation (0.5% FBS, 16 hours). Expression of FOXO3A is normalized 
with 18s rRNA, and the fold change for each gene is calculated by the 2
-ΔΔCq
 method. 
 
 
4.4.2 FOXO3A expression is regulated by insulin and cytokines at different time points 
in THP-1 monocytes. 
 
IL-1β and TNF-α are produced and secreted by monocytes and monocyte-derived 
macrophages and play an important role in the development of inflammatory diseases [108, 
109]. Recently, TNF has been shown to induce the translocation of nuclear FOXO3A into 
cytosol, and thereby decrease its transcriptional activity in human intestinal epithelial cells 
[110]. Other cytokines, including IL-2, IL-3 and IL-4 have also been reported to induce 
FOXO3A relocalization through the PI3K/Akt-pathway in mice [111, 112]. FOXO3A 
transcription factor has important, but cell type specific roles in the regulation of 
inflammatory processes [59, 60]. It is therefore of interest to study the response on FOXO3A 
mRNA expression in THP-1 cells treated with IL-1β and TNF-α. 
The effect of insulin in FOXO3A gene expression was not very strong and varied to a great 
extent in the three dose-response experiments from the previous section. The 24 hours was not 
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necessarily the optimal treatment period to induce regulations of FOXO3A mRNA expression 
in THP-1 monocytes. Consequently, a time-course experiment with insulin, IL-1β and TNF-α 
treated cells was performed. 
THP-1 monocytes were treated with IL-1β, TNF-α, and insulin for 2, 4, 8, 12 and 24 hours. 
FOXO3A mRNA expression seemed to be affected in a time-dependent manner for both 
cytokines and insulin treatments compared to untreated cells (control) (figure 15). A decrease 
in FOXO3A mRNA expression can be observed already two hours after treatment, but reveals 
a maximal decrease in THP-1 cells treated with IL-1β, TNF-α or insulin for 4 hours. THP-1 
cells stimulated for 8, 12 and 24 hours show the same tendency of reduced FOXO3A mRNA 
expression, but not with the same response as the 4 hours treatment. The experiment was 
repeated and resulted in similar observations (figure not shown). Consequently, THP-1 cells 
were treated with IL-1β, TNF-α and insulin for 4 hours in further experiments.  
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Figure 15: Fold change of FOXO3A mRNA compared to control (C). THP-1 cells (49 
passages) were treated with IL-1β (10 ng/mL), TNF-α (10 ng/mL) and insulin (0.01 µM) in 
0.5% FBS for the selected time points after serum starvation (0.5%, 16 hours). Expression of 
FOXO3A is normalized with 18s rRNA, and the fold change is calculated by the 2
-ΔΔCq
 
method. Error bars represent the SD for two different cDNA syntheses to illustrate technical 
variances. The experiment was repeated and resulted in similar observations  
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4.4.3 Expression of FOXO3A is significantly down-regulated by insulin, TNF-α and 
IL-1β in THP-1 monocytes 
 
FOXO3A mRNA expression in THP-1 cells treated with IL-1β, TNF-α or insulin for 4 hours 
were significantly down-regulated compared to untreated cells (control) (figure 16). A 0.48-
fold change can be observed for IL-1β-treated cells, a 0.55-fold change for TNF-α-treated 
cells and a 0.52-fold change for insulin-treated cells compared to the untreated cells. This 
demonstrates that FOXO3A is significantly regulated at an early time point in response to 
insulin and cytokine stimulation in THP-1 monocytes. These results are based on four 
independent experiments. 
 
 
Figure 16: Fold change of FOXO3A mRNA compared to control. THP-1 cells (passage 
number < 50) were treated with, IL-1β (10 ng/mL), TNF-α (10 ng/mL) and insulin (0.01 µM) 
in 0.5% FBS for 4 hours, after serum starvation (0.5% FBS, 16 hours. Expression of 
FOXO3A is normalized with 18s rRNA. The fold change was calculated by the 2
-ΔΔCq
 method 
and represents the mean of three independent experiments. * indicates a significant difference 
(p<0.016) after a Bonferroni correction. Error bars show a 95% confidence interval for the 
true values of the fold change.  
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4.4.4 Regulation of FOXO3A mRNA expression by combinations of insulin and 
cytokines 
 
THP1-cells treated with IL-1β, TNF-α or insulin for 4 hours did all reveal a significant 
reduced transcription of FOXO3A compared to untreated cells (see section 4.4.3). Due to 
these observations, THP-1 cells were treated with different combinations of the stimulating 
factors in order to investigate the possibilities for any additive, synergetic or even an 
antagonistic effect.   
THP-1 cells were treated with the following combinations of IL-1 β, TNF-α and insulin; IL-1 
β in combination with insulin, IL-1β in combination with TNF-α, TNF-α in combination with  
insulin, and TNF-α  in combination with insulin and IL-1β. In the same set of experiments 
THP-1 cells were also treated with IL-1β, TNF-α and insulin to compare any cooperative 
effect with the response of the stimulating factors alone.  
As in previous experiments, FOXO3A mRNA expression in THP-1 cells treated with IL-1β, 
TNF-α and insulin seems to be impaired compared to untreated THP-1 cells (control). The 
fold change of FOXO3A mRNA expression in cells treated with IL-1β, TNF-α and insulin is 
0.47, 0.54 and 0.51 respectively (figure 17). Regarding the different combinations, all the 
listed combinations gave a similar effect, and none of the treatments reported any cooperative 
effect. The combination of IL-1β and insulin can be seen with a fold change of 0.43 for 
FOXO3A mRNA expression, while insulin in combination with TNF-α reveals a 0.54-fold 
change. THP-1 cells treated with a combination of the two cytokines show a 0.51-fold change 
of FOXO3A mRNA expression compared to untreated cells. Finally, the fold change of 
FOXO3A in THP-1 cells treated with a combination of insulin with IL-1β and TNF-α is 0.44. 
This experiment was repeated and revealed similar results (not shown).  
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Figure 17: Fold change of FOXO3A compared to control. THP-1 cells (13 passages) were 
treated with IL-1β (10 ng/mL), TNF-α (10 ng/mL), insulin (0.01 µM) and listed combinations 
in 0.5% FBS for 4 hours, after serum starvation (0.5% FBS, 16 hours). Expression of 
FOXO3A is normalized with 18s rRNA. Fold change is calculated by the 2
-ΔΔCq
 method, and 
error bars represent standard deviation between two cDNA-syntheses to illustrate technical 
variables. The experiment was repeated and revealed similar results (not shown). 
 
  
4.5 Expression of the FOXO3A downstream target genes TRAIL, TWIST1 
and BTG1 is significantly upregulated in a synergistic manner in response to a 
combination of insulin, IL-1β and TNF-α  
 
The transcription factor FOXO3A has an important role in a variety of cellular processes 
through the regulation of several genes involved in development, differentiation, metabolism, 
cell growth, inflammation and longevity [52-54]. As the transcription of FOXO3A was 
reduced in response to insulin and cytokines in the current study, we wanted to investigate if 
this down-regulation is reflected in FOXO3A downstream target genes. As mentioned in 
section 2.6, expression of TRAIL, TWIST1 and BTG1 has all been demonstrated to be 
regulated by FOXO3A transcription factor. However, this effect has not yet been reported for 
THP-1 monocytes. 
TRAIL, TWIST1 and BTG1 have also been reported to be regulated by IL-1β, TNF-α and/or 
insulin; Insulin has been shown to down-regulate the pro-apoptotic ligand TRAIL in vascular 
0,0
0,2
0,4
0,6
0,8
1,0
1,2
F
o
ld
 c
h
a
n
g
e 
FOXO3A 
(4 hours) 
  4. Results 
48 
 
smooth muscle cells [113]. IL-1β and TNF-α on the other hand, induced TRAIL transcription 
in fetal astrocytes [114], but had no effect on TRAIL mRNA levels in T lymphocytes [115]. 
Furthermore, it has been shown that insulin and the insulin-like growth factor I (IGF-1) 
induce mRNA expression of TWIST1  in NIH-3T3 cells (mouse embryo fibroblast cell line) 
[116].  TWIST1 has also been suggested to be a target gene for the transcription factor NF-κB 
in the human HeLa cell line, induced by TNF-α [117]. Another pro-apoptotic gene, BTG1, 
has been reported to be transcriptionally regulated by insulin in human breast cancer cells 
[118].  
THP-1 cells were stimulated with IL-1β, TNF-α and insulin, and with a combination of these 
stimulation factors for 24 and 12 hours. Two sets of cDNA were synthesized from the  RNA 
representing the experimental conditions and used as template for qPCR with primers for 
TRAIL, TWIST1, BTG1 and 18s rRNA.  
IL-1β, TNF-α and insulin seemed to affect TRAIL and TWIST1 mRNA expression levels, 
whereas combinations of all three resulted in a synergistic significant up-regulation (figure 
18). TRAIL mRNA expression in THP-1 cells treated with TNF-α was significantly up-
regulated. The fold change of TRAIL mRNA expression in IL-1β-, TNF-α- and insulin treated 
cells compared to untreated cells is 1.4, 2.4 and 1.4 respectively, while cells treated with 
combinations show an 8.2-fold in TRAIL mRNA expression. mRNA expression of TWIST1 
shows a 2.1, 1.6 and 3.3-fold change in response to IL-1β, TNF-α and insulin, while 
combinations of insulin and cytokines resulted in a 7.8-fold change. The synergistic effect 
from cytokines and insulin was also observed in BTG1, but BTG1 mRNA expression seemed 
to be unaffected by the stimulation factors alone. Negligible regulations were shown for IL-
1β-, TNF-α- and insulin, but a 4.0-fold change in BTG1 mRNA expression can be seen when 
cells were stimulated with combination of insulin and cytokines. The mean value of the fold 
change represents data from two (TWIST1) and three (TRAIL and BTG1) biological 
replicates. THP-1 cells treated with insulin and cytokines for 12 hours did not show the same 
induction as the 24 hours treatment period, and was therefore not used for further experiments 
(not shown).   
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Figure 18:  Fold change of TRAIL, TWIST1 and BTG1 compared to control. THP-1 cells (13 
passages) were treated with IL-1β (10 ng/mL), TNF-α (10 ng/mL), insulin (0.01 µM) and 
combinations in 0.5% FBS for 24 hours, after serum starvation (0.5% FBS, 16 hours) 
Expression of target genes is normalized with 18s rRNA, and the fold change between treated 
and untreated cells (passage number 13) is calculated by the 2
-ΔΔCq
 method. * indicates a 
significant difference (p<0.016/p<0.025) after a Bonferroni correction, based on a two-tailed 
t-test with 95% confidence interval. Error bars represent SD between three (TRAIL and 
BTG1) and two (TWIST1) independent experiments.  
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4.6 Changes in gene expression due to passage number 
 
At some point during this study, the effects of insulin and cytokines shown in FOXO3A and 
desaturase mRNA expressions were difficult to reproduce after the THP-1 cells had reached a 
certain passage number. Consequently, it was of interest to investigate if the response was 
influenced by changes in phenotypes due to the increasing passage number. Chemokine (C-C 
motif) ligand 2 (CCL2) and IL-6 (interleukin-6) have been shown to be upregulated in 
response to TNF-α [119, 120] and were therefore used as “positive controls”. cDNA from 
TNF-α treated (10 ng/mL, 24 hours) and untreated (control) THP-1 cells with different 
passage number (49 and 59) were used as template for qPCR with primers for IL-6, CCL2 and 
18s rRNA. 
 
        
Figure 19: Fold change of IL-6 and CCL2 compared to control. THP-1 cells were treated 
with TNF-α (10 ng/mL) in 0.5% FBS for 24 hours, after serum starvation (0.5% FBS, 16 
hours). Expression of IL-6 and CCL2 is normalized with 18s rRNA. Fold change between 
treated and untreated cells (passage number 49 and 59) is calculated by the 2
-ΔΔCq
 method. 
Error bars represents standard deviation between two cDNA-syntheses to illustrate technical 
variables. 
 
Induction of CCL2 mRNA expression is much more pronounced in THP-1 cells with low 
passage number; THP-1 cells with passage number 49 show a 76.4-fold increase, while a fold 
change of 50.6 can be seen in cells with passage number 59 between cells treated with TNF-α 
and untreated cells (figure 19). This trend was also observed for IL-6 mRNA expression 
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where THP-1 cells with passage number 49 show a 2.5-fold change, while cells with passage 
number 59 show a 1.1-fold change. 
Due to these observations, a new stock of THP-1 cells with passage number 11 was thawed 
and cultured for further experiments. A similar experiment was performed on these THP-1 
cells in order to investigate the responsiveness of TNF-α treated THP-1 cells with low passage 
number. Induction of CCL2 mRNA expression was much more pronounced in THP-1 cells 
with low passage number; Cells with passage number 13 show a 176-fold change, compared 
to cells with passage number 49 and 59 which show a 76- and a 51-fold change between TNF-
α-treated cells and untreated cells, respectively (figure 20).   
 
 
 
Figure 20: Fold change of CCL2 compared to control. THP-1 cells were treated with TNF-α 
(10 ng/mL) in 0.5% FBS for 24 hours after serum starvation (0.5% FBS, 16 hours). Fold 
change between treated and untreated cells (passage number 13, 49 and 59) is calculated by 
the 2
-ΔΔCq
 method. Expression of FOXO3A is normalized with 18s rRNA. 
 
Due to these observations, qPCR was performed on cDNA from THP-1 cells with passage 
number 13 treated with IL-1β, TNF-α and insulin, with primers for D5D, D6D, SCD and 
FOXO3A. The fold change values for FOXO3A and D5D mRNA expressions from insulin 
and cytokine treated THP-1 cells with various passage numbers reveal similar trends as 
observed for the CCL2 expression (Figure 21 and 22). 
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The regulation of D5D mRNA expression in response to the listed stimulation factors is more 
induced in THP-1 cells with passage 13 and 46, compared to 56 and 58. A similar pattern was 
also observed for D6D and SCD (not shown). The regulation of FOXO3A mRNA expression 
is more induced in treated THP-1 cells with a passage number below 50. 
 
Figure 21: Fold change of D5D compared to control. THP-1 cells were treated with TNF-α 
(10 ng/mL) in 0.5% FBS for 24 hours, after serum starvation (0.5% FBS, 16 hours). 
Expression of D5D is normalized with 18s rRNA. Fold change between treated and untreated 
cells is calculated by the 2
-ΔΔCq
 method for four independent experiments with specified 
passage number. Error bars represents standard deviation between two cDNA-syntheses to 
illustrate technical variables. 
 
 
Figure 22: Fold change of FOXO3A compared to control. THP-1 cells were treated with 
TNF-α (10 ng/mL) in 0.5% FBS for 4 hours, after serum starvation (0.5% FBS, 16 hours). 
Expression of FOXO3A is normalized with 18s rRNA. Fold change between treated and 
untreated cells is calculated by the 2
-ΔΔCq
 method for five independent experiments with 
specified passage number. Error bars represents standard deviation between two cDNA-
syntheses to illustrate technical variables. 
0,0
0,5
1,0
1,5
2,0
2,5
F
o
ld
 c
h
an
g
e 
D5D  #13
#46
#56
#58
0,0
0,2
0,4
0,6
0,8
1,0
1,2
Control IL-1β TNF-α Insulin
F
o
ld
 c
h
an
g
e 
FOXO3A #13
#49
#49
#61
#63
  5. Discussion 
53 
 
5 DISCUSSION  
 
THP-1 cells were used as a model system for circulating human monocytes in order to 
investigate the expression of selected genes were regulated by insulin and cytokines. In this 
study, gene expression of D5D, D6D and SCD was shown to be significantly up-regulated in 
THP-1 cells treated with insulin for 24 hours. Moreover, mRNA expression of the 
transcription factor FOXO3A was significantly down-regulated in THP-1 cells treated with 
insulin, IL-1β and TNF. However, neither FOXO3A nor the desaturases were cooperatively 
regulated by these stimulating factors. TRAIL, TWIST and BTG1 on the other hand, were 
demonstrated to be significantly up-regulated in a synergistic manner when insulin was 
combined with IL-1β and TNF-α in THP-1 cells treated for 24-hours.  
 
5.1 Validation of primer for FOXO3A 
 
According to BLAST, the FOXO3A primer used in this study is specific for FOXO3A. This 
primer recognizes sequences located in exon 3 and exon 4 in the FOXO3A gene. According 
to resent research, FOXO3A and the pseudogene FOXO3B share the entire sequence in exon 
2-4 [121]. These findings were published after the current experiments, and were therefore not 
possible to take into account. The possibility that the current primer might recognize the 
pseudogene has to be considered. However, the resulting dissociation curve with expected 
melting point from the qPCR and the pure qPCR product visualized by gel-electrophoresis 
with expected length, indicate that the primer pair is indeed specific for FOXO3A. Still, more 
research needs to be done in order to fully exclude the presence of any amplification of 
mRNA from the pseudogene FOXO3B. There has not been reported any pseudogenes related 
to the other genes analyzed in this study. Consequently, the primers were considered as 
specific for its target genes as all primers resulted in single dissociation curves during qPCR, 
and due to the fact that qPCR products revealed the expected length.  
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5.2 Evaluation of reference genes 
 
Prior to all gene transcription qPCR studies, it was essential to find one or more appropriate 
reference gene. The efficiency of amplification of D5D, D6D, SCD and FOXO3A were 
compared to the potential reference genes GAPDH, B2M, HPRT and 18s rRNA. Even though 
GAPDH seemed to be a proper gene for the normalization of the desaturases and FOXO3A, 
this reference gene was excluded at an early point because it has been reported to be regulated 
by insulin [122]. B2M and 18s rRNA were expressed at a higher level inTHP-1 cells 
compared to the target genes, while HPRT was less expressed. HPRT was therefore not used 
as a reference gene in the further experiments. Initially, both B2M and 18s rRNA were used as 
reference genes in order to ensure a proper normalization. Over time, the Cq-value of B2M 
seemed to view minor variations in response to the stimulation factors. To avoid unreliable 
normalizations in the further experiments only 18s rRNA were used as reference gene. The 
Cq values for 18s rRNA were stable throughout all qPCR analyses, and was therefore 
considered to be the most suitable reference gene. All gene-expression changes presented in 
this thesis is therefore calculated based on 18s rRNA mRNA expressions. Regarding the 
primers for TRAIL, BTG1 and TWIST1, only the primer pair for TRAIL did actually show 
similar amplification efficiency as the primer pair for 18s rRNA.  
 
5.3 THP-1 as a model system for circulating monocytes 
 
The THP-1 cell line is one of the most widely used cell lines to investigate the regulation and 
function of human monocytes and macrophages. Several reports have demonstrated that this 
cell line is suitable for studying circulating monocytes in inflammation, obesity and diabetes-
related studies [83, 84, 123] . Therefore, we chose to utilize THP-1 cells as a model system to 
study the possible role of insulin and cytokines in the regulation of inflammation related 
genes in human monocytes.  
As the THP-1 monocytes are used to demonstrate features of circulating monocytes, it is 
appropriate to keep the cells at a low passage number. Circulating monocytes do not divide 
after leaving the bone marrow [124], and will therefore never obtain a high passage or 
generation number in vivo. 
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5.4 Passage number affected gene expression in THP-1 monocytes 
 
It has been demonstrated that a high passage number may influence cell morphology, growth 
rate and gene expression compared to cells with a low passage number [85, 86]. 
At some point during this study, results from previous experiments were difficult to repeat. 
The THP-1 cells seemed to be less responsive to the various stimulations, even though the 
protocols were standardized for all experiments. D5D, D6D and SCD mRNA, which had 
shown to be significantly induced by insulin previous in this study (see figure 11, section 
4.3.2), started to be less responsive at the time when experiments were performed to 
investigate insulin- and cytokine-treated THP-1 cells. This became an actual challenge during 
investigations of FOXO3A mRNA expression. In the first two experiments FOXO3A mRNA 
levels were clearly reduced in THP-1 cells treated with insulin and cytokines for 4 hours 
compared to untreated cells. In the following sets of experiments, performed with the same 
protocol, the down-regulation of FOXO3A mRNA levels was barely noticeable. Several 
experiments were performed in an attempt to achieve the same regulative effect shown in 
previous experiments. At this point, the number of cell passages was actually above 60. 
Passage number related phenotypic alterations were suggested to be the reason for the reduced 
responsiveness.  
In order to investigate the responsiveness in THP-1 cells with various passage numbers, 
CCL2 and IL-6 mRNA expressions were studied in TNF-α-treated THP-1 cells. TNF-α is 
reported as an inducer for CCL2 and IL-6 transcription [119, 120]. As predicted, cells with 
low passage number were more responsive to the TNF-α treatment compared to cells with a 
high passage number. A similar trend was demonstrated for the desaturases and FOXO3A. 
These observations demonstrate that the quality of the THP-1 cell line is essential in order to 
perform successful experiments. There are no tests that directly determine the passage-related 
effects in a cell line. It is therefore necessary to pay attention to passage numbers in case it 
might affect the research results. Keeping the cells at a low passage number seems to 
contribute to reliable and reproducible results.  
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5.5 D5D, D6D and SCD mRNA expression is significantly induced by 0.01 µM 
insulin in THP-1 monocytes 
 
D5D, D6D and SCD have been shown to be expressed in THP-1 monocytes in previous 
studies [27, 125]. Recently, Arbo et al [27] demonstrated a significant up-regulation of D5D, 
D6D and SCD mRNA expression in THP-1 cells treated with 10 µM insulin for 24 hours. 
However, concentrations from 10 µM and down to 0.001 µM insulin have been used in 
similar experiments [102, 103, 105], and were therefore all considered to be potential insulin 
concentrations for this study.  
Results from the current study confirmed that D5D, D6D and SCD are expressed in THP-1 
monocytes. Here, desaturase mRNA expression was significant up-regulated in THP-1 cells 
treated with 0.01 µM insulin for 24 hours.  
These observations demonstrate that THP-1 cells are sensitive for insulin treatment at low 
concentration as well. The insulin concentration of 0.01 µM is 100 times lower than the 
concentration used in Arbo et al [27]. The insulin-treatment period of 24 hours used in the 
current study is consistent with previous similar experiments [27, 102-105]. 
As insulin levels increase in response to elevated circulating glucose after a meal in vivo [17], 
and insulin has been demonstrated to increase expression levels of desaturases in this study, 
PUFA metabolism and further inflammation-related eicosanoids might be influenced by 
nutrient composition in meals. As the mRNA expression of desaturases is positively regulated 
by insulin in THP-1 cells, a similar response might be true for circulating blood cells. 
However, investigations of D5D, D6D and SCD need to be performed to understand how the 
enzyme activity is regulated before such a conclusion can be made. 
 
5.6 FOXO3A mRNA expression is significantly down-regulated by insulin in 
THP-1 monocytes 
 
Insulin has been reported to regulate the biological activity of FOXO3A through the 
PI3K/Akt-pathway [22, 71]. Although the post-transcriptional regulations of FOXO3A in 
response to insulin have been well investigated, the molecular mechanisms that regulate 
FOXO3A mRNA expression levels remain mostly unclear.  
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Elevated levels of FOXO3A mRNA expression have been observed in rats after 48 hours of 
fasting [107]. When the rats were fed for 3 hours after the fasting, the induced FOXO3A 
mRNA expression went back to levels observed before fasting. In contrast to these findings 
Imea et al [107] also demonstrated a reduced FOXO3A mRNA expression in response to 
insulin deficiency in rats. Furthermore, Imea et al suggest that this suppression of FOXO3A 
mRNA occurs in order to assuage the excessive actions of FOXO3A transcription factor, as 
insulin deficiency keeps FOXO3A inside the nucleus. In order to examine the regulative role 
of insulin, we investigated FOXO3A mRNA expression levels in insulin-treated THP- 1 
monocytes. 
FOXO3A was expressed in THP-1 monocytes in the current study, which is consistent with 
previous findings [126, 127]. Here, for the first time a significant down-regulation of 
FOXO3A expression by insulin in THP-1 monocytes was demonstrated. These observations 
support previous findings and theory saying that regulation of FOXO3A may be related to the 
glucose-metabolism. However, it is in contrast to findings by Imae et al [107], where a 
decrease in FOXO3A mRNA expression was reported in the liver from insulin deficiency 
rats. These contrary findings emphasize that FOXO3A may have cell specific roles.  
 
5.7 FOXO3A mRNA expression is significantly down-regulated by cytokines in 
THP-1 monocytes 
 
In previous studies, TNF-α has been shown to induce the translocation of nuclear FOXO3 by 
phosphorylation, and thereby regulate the transcriptional activity in human intestinal epithelial 
cells [110]. Interleukins, including IL-2, IL-3 and IL-4 have also been reported to induce 
FOXO3A phosphorylation through the PI3K/Akt-pathway in mice [111, 112]. As FOXO3A 
transcription factor are active in mediating inflammatory processes [59, 60], it was of interest 
to investigate FOXO3A mRNA levels in relation to the proinflammatory cytokines IL-1β and 
TNF-α in THP-1 monocytes.  
In this study, a significant down-regulation in FOXO3A gene expression was observed in 
THP-1 monocytes only four hours after TNF-α and IL-1β were added to the cells.  
From these results it appears that the regulation of FOXO3A transcription in THP-1 cells are 
indeed responsive to cytokines, and this might reflect similar events in circulating monocytes 
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during inflammation. These observations support previous findings where FOXO3A has been 
suggested to be an important transcription factor involved in several inflammatory processes 
[59, 60].    
 
5.8 TRAIL mRNA expression is significantly induced by TNF-α in THP-1 
monocytes 
 
Besides being an inducer for apoptosis in tumor- and virally infected cells, previous studies 
have demonstrated that TRAIL induce transcription of inflammatory related genes [128, 129]. 
Tang et al [128] suggest that TRAIL is able to induce the release of cytokines through 
activation of NF-κB. The transcription factor NF-κB, which also is induced by TNF-α, 
regulates a wide range of genes involved in inflammatory processes [51]. TWIST1 has also 
been related to inflammatory processes, as it has been reported to regulate the expression and 
secretion of several inflammatory adipokines in human white adipocytes [61]. This gene has 
also been reported as a target for NF-κB induced by TNF-α [117]. TWIST mRNA expression 
has also be shown to be up-regulated by insulin and IGF-1 in NIH-3T3 cells [116]. Regulation 
of the apoptosis-promoting BTG1 gene has not yet been directly related to inflammation, but 
an increase in gene expression by insulin has been demonstrated in human cancer cells [118]. 
In this study, TRAIL, BTG1 and TWIST1 were all expressed in THP-1 monocytes. These 
results support previous findings [130-133]. Furthermore, a significant up-regulation of 
TRAIL transcription in THP-1 cells treated with TNF-α was demonstrated. These results 
support the theory from Tang et al [128] saying that TRAIL participates in several 
inflammatory events.  These results also suggest that TRAIL is induced by TNF-α in human 
monocytes in vivo.  
It is worthwhile to note that TWIST1 seems to be affected by insulin and IL-1β in the current 
study. As FOXO3A has been shown to inhibit transcription of TWIST1 [63], and FOXO3A 
mRNA expression was down-regulated by insulin and IL-1β in the current study, there might 
be a possibility that the observed induction of TWIST1 mRNA expression is linked to 
FOXO3A inhibition caused by insulin and IL-1β. However, more experiments need to be 
performed in order to clarify if TWIST1 in fact is regulated by IL-1β or insulin, and to reveal 
the role of the FOXO3A transcription factor in this potential pathway.  
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As BTG1 expressions seemed to be unaffected in THP-1 cells treated with separated 
stimulation factors, the 24 hours-stimulation may not be the optimal treatment period. This 
also applies to the regulation of TRAIL and TWIST1 expression. A more obvious induction 
might occur if THP-1 cells were incubated with insulin and cytokines for a longer time 
period. For instance, 48 or 72 hours have been used to demonstrate cytokine-regulated 
transcriptional activity [134, 135].  
 
5.9 Insulin and cytokines induce expression of TRAIL, TWIST1 and BTG1 in 
a synergistic manner in THP-1 monocytes  
 
IL-1β and TNF-α have previously been reported to demonstrate a synergistic effect in the 
regulation of gene transcription [134]. Moreover, insulin has been shown to enhance 
cytokine-induced inflammation-related gene transcription in hepatocytes [136]. Okazaki et al 
[136] suggest that this cooperation may be part of the explanation why enhanced production 
of cytokines and hyperinsulinemia results in inflammation and metabolic syndromes. 
In this study, a significant increase in the transcription of TRAIL, TWIST1 and BTG1 in 
response to insulin combined with IL-1β and TNF-α in a synergistic manner in THP-1 
monocytes was demonstrated.  
The demonstrated synergistic effect between insulin and cytokines is consistent with previous 
findings, where insulin and IL-1β cooperatively increased mRNA expressions in a human 
hepatic cell line [136]. As discussed in the previous section, the induction of TWIST1 mRNA 
expression might involve the inhibition of FOXO3A activity by insulin and/or cytokines. The 
enhanced effect that was demonstrated for TRAIL and BTG1 in this study is in contrast to 
what we expected. As FOXO3A has been reported to induce TRAIL and BTG1 mRNA 
expression [65-68] and TNF-α and insulin have been shown to inhibit the transcriptional 
activity of FOXO3A [22, 71, 110], a reduced mRNA expression of TRAIL and BGT1 was 
expected. Thus, this observed induction of TRAIL and BTG1 expression probably involves 
other regulatory factors. 
Insulin in combination with IL-1β and TNF-α did not demonstrate any cooperative effect in 
the regulation of FOXO3A mRNA expression. Regarding the regulation of D5D, D6D and 
SCD mRNA expression, more investigations need to be done to reveal any regulative effect of 
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IL-1β and TNF-α. However, it is worthwhile to note that IL-1β seemed to inhibit the 
induction of desaturases caused by insulin as shown in figure 13. This negative regulation of 
insulin signaling is discussed by Osborne and Olefsky [137], where cytokines including IL-1β 
is suggested to contribute to induce insulin resistance. Thus, this regulative effect should be 
further explored in THP-1 cells. 
 
5.10 Conclusion 
 
THP-1 cells were used as a model system for circulating human monocytes in order to reveal 
possible alterations in expression of inflammatory-related genes in response to insulin and 
cytokines. 
Gene expression of the fatty acids desaturases D5D, D6D and SCD was significantly up-
regulated by 0.01 µM insulin in THP-1 cells after a 24-hours treatment. This response has 
been demonstrated before, but with a higher concentration of insulin. Here it is shown that 
THP-1 cells are sensitive also to lower concentrations of insulin. FOXO3A mRNA expression 
was significantly down-regulated by insulin, IL-1β and TNF-α. These observations strengthen 
the suggested inflammatory role of FOXO3A. A maximum regulation of FOXO3A was 
observed after a four-hours treatment with insulin and cytokines. This indicates that FOXO3A 
is transcriptionally regulated at an earlier exposure-time compared to the other genes that 
were examined in this study. TRAIL, TWIST and BTG1 were significantly up-regulated in 
THP-1 cells treated with a combination of insulin, IL-1β and TNF-α for 24 hours. The 
observed induction of TWIST1 mRNA expression might be linked to the demonstrated 
inhibition of FOXO3A caused by insulin, IL-1β and TNF-α.  
The demonstrated insulin- and cytokine-responsiveness in THP-1 cells suggests that this cell 
line is a suitable model-system for studying changes in gene expression of inflammatory-
related genes by cytokines and diet-related hormones.  
Moreover, it was demonstrated that high passage THP-1 cells were less responsive to 
treatment with insulin and cytokines than cells with a low passage number.  As previous 
studies have shown that certain cell lines reveal phenotypic alterations due to a high number 
of passages, it is likely to believe that the variable responsiveness observed in this study could 
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be explained by this feature. These observations demonstrate the importance of keeping THP-
1 cells at a low passage number during experiments.  
The gene-environment interactions in diseases like diabetes, obesity, CVD and other 
inflammatory-related diseases are still poorly understood. More studies need to be performed 
in order to understand how nutrition affects these metabolic disorders. The research results 
presented in this study might be a minor contribution to the bulk of knowledge that is needed 
to fully understand these issues.  
 
5.11 Proposals for further research 
 
5.11.1 Further studies of the effect of cytokine on desaturase expression 
 
The mRNA expression levels of D5D, D6D and SCD were all significantly up-regulated in 
response to insulin in THP-1 monocytes. These observations were done in experiments 
performed on cells with low passage number. During the time when THP-1 cells were treated 
with cytokines, the passage number was considerably higher. As the passage number seemed 
to be a critical factor for the responsiveness to insulin and cytokines in THP-1 cells, this 
probably caused the variable response in expression of mRNA that were observed in the 
experiments. Consequently, regulation of mRNA expression of D5D, D6D and SCD by IL-1β 
and TNF-α should be investigated in low passage THP-1 cells to determine any regulative 
effect. 
 
5.11.2 Further optimization of in vitro conditions 
 
The dose-response experiment for FOXO3A was performed on THP-1 cells treated with 
insulin for 24 hours. As the 24 hours period was not the optimal treatment period in order to 
achieve the maximum regulation of FOXO3A expression by insulin, additional experiments 
should be performed on THP-1 cells treated with various concentrations of insulin for four 
hours. Various concentrations of cytokines should also be examined in order to find the 
optimal concentrations for a maximum regulation of desaturases, FOXO3A, TRAIL, TWIST1 
and BTG1. Furthermore, a set of dose-response experiments should be performed in order to 
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find the optimal concentrations of IL-1β and TNF-α for achieving maximum regulation of 
gene expressions.  
During investigations of TRAIL, TWIST1 and BTG1, THP-1 cells were stimulated with 
insulin and cytokines for 12 and for 24 hours. The cells were more responsive to the 24 hours-
treatment. Consequently, this period was selected for further studies. The 24 hours period may 
not necessarily be the optimal time period in order to achieve maximal regulation of gene 
expression. Consequently, THP-1 cells should be treated with insulin and cytokines for a 
longer period to reveal possible higher response in the regulation of TRAIL, TWIST1 and 
BTG1 mRNA expression.  
 
5.11.3 Combinations of insulin and cytokines in the regulation of TRAIL, TWIST1 and 
BTG1 
 
mRNA expression of TRAIL, TWIST and BTG1 were only analyzed in THP-1 cells treated 
with insulin, IL-1β and TNF-α alone or with combination of all three. Different combinations 
of cytokines and insulin should be studied in the same was as in the current study of FOXO3A 
and the desaturases. Due to the fact that the combination of insulin with both cytokines 
induced mRNA expression of TRAIL, TWIST and BTG1 in a synergistic manner, it is of 
interest to study THP-1 cells treated with insulin in combination with IL-1β, IL-1β in 
combination with TNF-α, and TNF-α in combination with insulin. In this way it is possible to 
see how these stimulation factors act in cooperation with each other in the process of 
stimulating mRNA expression of the relevant genes.  
 
5.11.4 Investigate the regulations at translation and post-translation levels 
 
As mentioned in section 2.3, proteins can be regulated at several levels. In this study, genes 
were only investigated at the transcriptional level. Even though current observations suggest a 
potential relation between these genes and the inflammatory processes in our body, more 
investigations need to be done before a conclusion can be drawn. Consequently, regulation of 
FOXO3A, desaturases, TRAIL, TWIST1 and BTG1 by insulin and cytokines should be 
investigated at protein levels in THP-1 cells in further studies. These studies should include 
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investigating the activity of the transcription factors and the enzymatic activity of the 
desaturases. The possible involvement of FOXO3A in the up-regulation of TWIST1 should 
also be investigated.  
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Appendix 
 
Paired, two-tailed Student T-test was used to compare the mean of the ΔCq-values for treated 
cells with the ΔCq-values for untreated cells (control) in relation to the variation in the data. 
P-values for the T-test performed on relevant genes are listed in table A. p-values that are 
considered significant after a Bonferroni correction are written in bold. 
Table A: p-values for the T-tests performed in this study. p-values that are considered 
significant are written in bold. 
Treatment Gene p-value 
  D5D 0.001 
  D6D 0.002 
  SCD 0.005 
Insulin FOXO3A 0.014 
  TRAIL 0.378 
  BTG1 0.623 
  TWIST1 0.060 
  FOXO3A 0.006 
IL-1β TRAIL 0.043 
  BTG1 0.711 
  TWIST1 0.062 
  FOXO3A 0.002 
TNF-α TRAIL 0.008 
  BTG1 0.887 
  TWIST1 0.450 
  TRAIL 0.002 
Insulin/IL-1β/TNF-α BTG1 0.005 
  TWIST1 0.020 
 
 
 
